BridgeBio Oncology Therap... (BBOT)
NASDAQ: BBOT
· Real-Time Price · USD
11.47
-0.23 (-1.97%)
At close: Sep 29, 2025, 3:59 PM
11.35
-1.05%
After-hours: Sep 29, 2025, 07:29 PM EDT
-1.97% (1D)
| Bid | 10.81 |
| Market Cap | 908.39M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 4.72M |
| EPS (ttm) | -1.1 |
| PE Ratio (ttm) | -10.43 |
| Forward PE | -5.2 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 12.15 |
| Volume | 464,844 |
| Avg. Volume (20D) | 206,680 |
| Open | 11.22 |
| Previous Close | 11.70 |
| Day's Range | 10.85 - 11.70 |
| 52-Week Range | 8.50 - 12.50 |
| Beta | -0.23 |
| Ex-Dividend Date | n/a |
About BBOT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BBOT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BBOT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+8.01%
BridgeBio Oncology Therapeutics shares are trading...
Unlock content with
Pro Subscription
1 month ago
+13.43%
BridgeBio Oncology Therapeutics shares are trading higher after Wedbush initiated coverage on the stock with an Outperform rating and announced a price target of $25.